Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10835302 | Nitric Oxide | 2005 | 10 Pages |
Abstract
TGF-β1 is a well-known immunosuppressive cytokine that inhibits inducible nitric oxide synthase (iNOS) gene expression in various cells including macrophages. In this study, we investigated the suppressive mechanisms of TGF-β1 on IFN-γ-induced iNOS gene expression using the murine macrophage-like cell line RAW 264.7. TGF-β1 decreased iNOS protein amount through enhanced degradation, although TGF-β1 did not affect IFN-γ-induced iNOS mRNA level or stability. In addition, the enhancement of iNOS protein degradation by TGF-β1 treatment was almost completely blocked by MG132, a proteasome inhibitor. Furthermore, TGF-β1 enhanced the trypsin-like activity of proteasomes in the presence of IFN-γ, although did not enhance the peptidylglutamyl-peptide hydrolyzing and chymotrypsin-like activities of proteasomes. The level of ubiquitinated iNOS protein was not significantly altered by IFN-γ or IFN-γ plus TGF-β1 treatment. Because MG132 inhibited iNOS protein degradation and IFN-γ plus TGF-β1 treatment increased the trypsin-like activity of proteasomes, we hypothesized that TGF-β1 might enhance iNOS protein degradation via the ubiquitin-proteasome pathway in the presence of IFN-γ. We propose that these mechanisms of TGF-β1 in the posttranslational regulation of iNOS gene expression may contribute to suppression of excess nitric oxide during inflammatory processes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Toshifumi Mitani, Masaharu Terashima, Hitoshi Yoshimura, Yuko Nariai, Yoshinori Tanigawa,